Malvern, United States
Ception Therapeutics, Inc. is a biotechnology company based out of Malvern, Pennsylvania. Founded in 2004, the company operates in the Biotechnology, Health Care, and Information Technology industries. Ception Therapeutics is at the forefront of the biopharmaceutical sector, leading the charge in developing biological products capable of addressing a wide range of complex medical conditions.
The company's latest investment round saw a significant infusion of $14.70M in a Series C financing on 31 May 2007. This funding was secured from noteworthy investors including Third Point Ventures and Greenlight Capital.
With its robust focus on innovation and a mission to tackle challenging medical afflictions, Ception Therapeutics, Inc. continues to draw attention from venture capital firms and investors. Its location in the United States also places it within the thriving landscape of the biotechnology and healthcare sectors in the region.
